We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00452777
Recruitment Status : Completed
First Posted : March 27, 2007
Last Update Posted : November 3, 2014
Sponsor:
Information provided by (Responsible Party):
Swedish Orphan Biovitrum

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2007
  Study Completion Date : January 2008